Xiaomi introduced the Redmi Turbo 4 smartphone in January, and now it is gearing up for a new launch this week. The company confirmed that the Redmi Turbo 4 Pro will officially arrive on Thursday ...

Xiaomi on Monday (April 21, 2025) launched its first locally manufactured smartwatch Redmi Watch Move in India. The smartwatch has been made at Optiemus’s factory in Noida. Redmi Watch Move has ...

KOMPAS.com - Sub merek dari Xiaomi, Redmi merilis arloji pintar (smartwatch) terbarunya, yaitu Redmi Watch Move, di pasar India, Senin (21/4/2025). Redmi Watch Move dijual dengan harga yang cukup ...

Xiaomi has launched its first locally manufactured smartwatch, the Redmi Watch Move. It’s designed for everyday fitness, health tracking, and smart task management. The Redmi Watch Move is ...

Pemerintahan Trump mulai mengadakan pembicaraan dengan mitra dagangnya—termasuk Indonesia—mengenai kebijakan tarif pajak impor AS yang kontroversial. Delegasi Jepang mengunjungi Washington ...

Kasus aparat hukum mempermasalahkan produk pemberitaan yang dikaitkan dengan perintangan penyidikan diyakini baru pertama kali terjadi di Indonesia, menurut sejumlah kalangan. Mereka khawatir ...

That is a wild overreaction to Game 1s of their series, but someone might as well say it. Guile meant nothing for the Lakers on Saturday, when the Timberwolves ran them out of the gym, and it ...

Premier League telah lama menjadi salah satu kompetisi domestik terpopuler di seantero dunia, tak terkecuali Indonesia, dengan klub-klub top seperti Manchester United, Liverpool, Arsenal ...

Read all about why we recommend these and more in this list of the best 2-in-1s to buy right now, based on our hands-on testing and reviews! The quick list In a hurry? Here's a brief overview of ...

Main Camera Quad 50 MP, f/1.9 or f/4.0, 23mm (wide), 1.0"-type, 1.6µm, dual pixel PDAF, OIS 50 MP, f/1.8, 75mm (telephoto), 1/2.51", 0.7µm, dual pixel PDAF, OIS, 3 ...

In a short but wide-ranging conversation, Hilberdink, who was only about a month into his job at the time, talked about the opportunity in GLP-1s, transparency in drug pricing, and the Trump ...